Cidara Therapeutics, Inc.
CDTX Real Time Price USDRecent trades of CDTX by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by CDTX's directors and management
Government lobbying spending instances
-
$10,000 Oct 19, 2020 Issue: Medical/Disease Research/Clinical Labs Budget/Appropriations
-
$20,000 Jul 15, 2020 Issue: Budget/Appropriations Medical/Disease Research/Clinical Labs
-
$20,000 Apr 16, 2020 Issue: Budget/Appropriations Medical/Disease Research/Clinical Labs
Estimated quarterly lobbying spending
New patents grants
-
Patent Title: Compositions and methods for the treatment of viral infections Dec. 05, 2023
-
Patent Title: Compositions and methods for the treatment of fungal infections Nov. 21, 2023
-
Patent Title: Dosing regimens for treatment of fungal infections Aug. 01, 2023
-
Patent Title: Dosing regimens for echinocandin class compounds May. 23, 2023
-
Patent Title: Synthesis of echinocandin antifungal agent Dec. 13, 2022
-
Patent Title: Compositions and methods for the treatment of viral infections Nov. 29, 2022
-
Patent Title: Compositions and methods for the treatment of fungal infections Dec. 14, 2021
-
Patent Title: Methods for preventing and treating pneumocystis infections Sep. 22, 2020
-
Patent Title: Dosing regimens for echinocandin class compounds Jul. 07, 2020
-
Patent Title: Methods for preventing and treating pneumocystis infections Aug. 06, 2019
-
Patent Title: Dosing regimens for echinocandin class compounds Jul. 10, 2018
-
Patent Title: Antifungal agents and uses thereof Jun. 13, 2017
-
Patent Title: Dosing regimens for echinocandin class compounds Dec. 27, 2016
-
Patent Title: Antifungal agents and uses thereof Dec. 22, 2015
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Number of mentions of CDTX in WallStreetBets Daily Discussion
Recent insights relating to CDTX
Recent picks made for CDTX stock on CNBC
ETFs with the largest estimated holdings in CDTX
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view CDTX Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.